Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity
Authors
Keywords
Children, Familial hypercholesterolemia, LDL-cholesterol, Lipoprotein apheresis prevention, Treatment
Journal
PEDIATRIC NEPHROLOGY
Volume 33, Issue 7, Pages 1199-1208
Publisher
Springer Nature
Online
2018-03-04
DOI
10.1007/s00467-018-3906-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol
- (2017) Gilbert R Thompson et al. EUROPEAN HEART JOURNAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
- (2017) Frederick J Raal et al. Lancet Diabetes & Endocrinology
- Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular DiseaseHighlights
- (2016) Eberhard Roeseler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
- (2016) Michael France et al. ATHEROSCLEROSIS
- Phenotype diversity among patients with homozygous familial hypercholesterolemia: A cohort study
- (2016) Frederick J. Raal et al. ATHEROSCLEROSIS
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia
- (2016) Christina Taylan et al. Journal of Clinical Lipidology
- Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis
- (2016) Claudia Stefanutti et al. Journal of Clinical Lipidology
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
- (2016) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
- (2016) Raul D Santos et al. Lancet Diabetes & Endocrinology
- TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose
- (2015) U. Schatz et al. ATHEROSCLEROSIS SUPPLEMENTS
- Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany
- (2015) Franz Heigl et al. ATHEROSCLEROSIS SUPPLEMENTS
- Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study
- (2015) L. Fernandez-Friera et al. CIRCULATION
- The Agenda for Familial Hypercholesterolemia
- (2015) Samuel S. Gidding et al. CIRCULATION
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
- (2014) Barbara Sjouke et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Apheresis in homozygous familial hypercholesterolemia: The results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
- (2012) Asgeir Græsdal et al. Journal of Clinical Lipidology
- Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
- (2011) Frederick J. Raal et al. CIRCULATION
- Sudden Death in a 4-Year-Old Boy: A Near-Complete Occlusion of the Coronary Artery Caused by an Aggressive Low-Density Lipoprotein Receptor Mutation (W556R) in Homozygous Familial Hypercholesterolemia
- (2010) Kurt Widhalm et al. JOURNAL OF PEDIATRICS
- Efficacy criteria and cholesterol targets for LDL apheresis
- (2009) Gilbert R. Thompson et al. ATHEROSCLEROSIS
- Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia
- (2008) Lisa C. Hudgins et al. AMERICAN JOURNAL OF CARDIOLOGY
- Update and Analysis of the University College London Low Density Lipoprotein Receptor Familial Hypercholesterolemia Database
- (2008) S. E. A. Leigh et al. ANNALS OF HUMAN GENETICS
- Low-density Lipoprotein Apheresis in Children With Familial Hypercholesterolemia: Follow-up to 21 Years
- (2008) Jean-Bernard Palcoux et al. THERAPEUTIC APHERESIS AND DIALYSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started